Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6ZLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,658
Award facts
- Contract value 100% obligated
- $22,658.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,658.48 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The awardee operates as a subsidiary of Cencora, Inc., the parent organization that also does business as AmerisourceBergen.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical Supply Chain, designated SPE2DX and valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This contract structure reflects the Defense Logistics Agency's strategy to maintain flexible and responsive pharmaceutical supply chains that can serve multiple federal customers, including the Defense Health Agency and the U.S. Coast Guard, across diverse therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DR26F6ZLM?
SPE2DR26F6ZLM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F6ZLM worth?
The government has obligated $22,658 on SPE2DR26F6ZLM.
Is contract SPE2DR26F6ZLM an order under another contract?
Yes. SPE2DR26F6ZLM is a delivery order under SPE2DR25D3803, an indefinite delivery contract.
Was contract SPE2DR26F6ZLM competed?
The extent of competition for SPE2DR26F6ZLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award